𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Administration of selegiline is not associated with visual hallucinations in advanced Parkinson's disease patients

✍ Scribed by S. Papapetropoulos; A.A. Argyriou

Book ID
116820029
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
58 KB
Volume
11
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cognitive correlates of visual hallucina
Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease
✍ Kolbjorn Bronnick; Murat Emre; Sibel Tekin; Siri B. Haugen; Dag Aarsland πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 109 KB πŸ‘ 1 views

## Abstract ## Background: There may be a relationship between cognitive impairment and visual hallucinations (VHs) in patients with Parkinson's disease (PD). The objective of this study was to compare the cognitive profile of hallucinating vs. nonhallucinating patients with Parkinson's disease de

Effects of rivastigmine in patients with
Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease
✍ David Burn; Murat Emre; Ian McKeith; Peter Paul De Deyn; Dag Aarsland; Chuanchie πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 190 KB πŸ‘ 1 views

## Abstract We aimed to determine prospectively whether rivastigmine, an inhibitor of acetylcholinesterase and butyrylcholinesterase, provided benefits in patients with and without visual hallucinations in a population with dementia associated with Parkinson's disease (PDD). This was a 24‐week doub